Proteios Technology
@proteiostech.bsky.social
Pioneering the future of protein purification.
RapidPro™ Protein Purfication Kits enable scientists to purify challenging proteins with high yield & purity—unlocking new possibilities in disease research and advanced therapeutics.
https://www.proteios.com
RapidPro™ Protein Purfication Kits enable scientists to purify challenging proteins with high yield & purity—unlocking new possibilities in disease research and advanced therapeutics.
https://www.proteios.com
The AptaCapture is the future for cell therapy for #rarediseases, and that starts with innovation:
✅ 99% purity in cell isolation (vs. 95%)
✅ 30-minute isolation (vs. 150+ min)
✅ 7.5x cell expansion (vs. 5x)
✅ Lower exhaustion marker (PD1: 32%), improving long-term efficacy #RareDiseaseResearch
✅ 99% purity in cell isolation (vs. 95%)
✅ 30-minute isolation (vs. 150+ min)
✅ 7.5x cell expansion (vs. 5x)
✅ Lower exhaustion marker (PD1: 32%), improving long-term efficacy #RareDiseaseResearch
February 28, 2025 at 8:40 PM
The AptaCapture is the future for cell therapy for #rarediseases, and that starts with innovation:
✅ 99% purity in cell isolation (vs. 95%)
✅ 30-minute isolation (vs. 150+ min)
✅ 7.5x cell expansion (vs. 5x)
✅ Lower exhaustion marker (PD1: 32%), improving long-term efficacy #RareDiseaseResearch
✅ 99% purity in cell isolation (vs. 95%)
✅ 30-minute isolation (vs. 150+ min)
✅ 7.5x cell expansion (vs. 5x)
✅ Lower exhaustion marker (PD1: 32%), improving long-term efficacy #RareDiseaseResearch
Cell therapy methods are slow, costly, and inefficient for #rarediseases. The Proteios AptaCapture Platform is here to fix that. By eliminating the need for antibodies & nanobeads, we’re making cell therapy faster, more scalable, and accessible for researchers & clinicians.
February 28, 2025 at 8:40 PM
Cell therapy methods are slow, costly, and inefficient for #rarediseases. The Proteios AptaCapture Platform is here to fix that. By eliminating the need for antibodies & nanobeads, we’re making cell therapy faster, more scalable, and accessible for researchers & clinicians.
Here’s what we found:
✔ KRAS, TEV protease, and PFK were purified with 85-95% purity.
✔ Yields reached up to 2mg in a single run.
✔ The workflow avoided toxic reagents and took less than 15 minutes.
The gel tells the story—clear, strong bands for some of the toughest-to-purify proteins!
3/3
✔ KRAS, TEV protease, and PFK were purified with 85-95% purity.
✔ Yields reached up to 2mg in a single run.
✔ The workflow avoided toxic reagents and took less than 15 minutes.
The gel tells the story—clear, strong bands for some of the toughest-to-purify proteins!
3/3
January 28, 2025 at 10:05 PM
Here’s what we found:
✔ KRAS, TEV protease, and PFK were purified with 85-95% purity.
✔ Yields reached up to 2mg in a single run.
✔ The workflow avoided toxic reagents and took less than 15 minutes.
The gel tells the story—clear, strong bands for some of the toughest-to-purify proteins!
3/3
✔ KRAS, TEV protease, and PFK were purified with 85-95% purity.
✔ Yields reached up to 2mg in a single run.
✔ The workflow avoided toxic reagents and took less than 15 minutes.
The gel tells the story—clear, strong bands for some of the toughest-to-purify proteins!
3/3
Hey BlueSky! 👋Proteios Technology here! We’re leveraging advances in protein engineering and gene synthesis to offer a brand-new recombinant protein purification method that’s rapid, simple, and safe. 🧪✨
Here is a brief introduction to our recent work! ⬇️ 1/5
Here is a brief introduction to our recent work! ⬇️ 1/5
November 27, 2024 at 9:57 PM
Hey BlueSky! 👋Proteios Technology here! We’re leveraging advances in protein engineering and gene synthesis to offer a brand-new recombinant protein purification method that’s rapid, simple, and safe. 🧪✨
Here is a brief introduction to our recent work! ⬇️ 1/5
Here is a brief introduction to our recent work! ⬇️ 1/5